Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
64.50
+1.55 (2.46%)
Dec 20, 2024, 4:00 PM EST - Market closed

Disc Medicine Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-103.48-76.43-46.83-35.97-20.94
Depreciation & Amortization
0.170.10.090.030.02
Stock-Based Compensation
14.415.532.090.510.12
Other Operating Activities
-1.110.290.276.610.32
Change in Accounts Payable
-5.11-3.740.531.32-0.51
Change in Other Net Operating Assets
14.060.791.6-0.031.01
Operating Cash Flow
-84.15-73.46-42.25-27.53-19.97
Capital Expenditures
-0.06-0.09-0.15-0.07-0.08
Investing Cash Flow
-290.91-0.09-0.15-0.07-0.08
Issuance of Common Stock
197.28201.8151.120.070
Other Financing Activities
-37.58-2.14--
Financing Cash Flow
197.28239.38148.9889.9334.98
Net Cash Flow
-177.78165.83106.5862.3314.94
Free Cash Flow
-84.21-73.55-42.4-27.6-20.04
Free Cash Flow Per Share
-3.21-3.30-40.79-31.42-2.89
Cash Income Tax Paid
0.070.11---
Levered Free Cash Flow
-54.26-54.31-19.91-10.87-
Unlevered Free Cash Flow
-54.26-54.31-19.91-10.87-
Change in Net Working Capital
-9.272.9-7.73-8-
Source: S&P Capital IQ. Standard template. Financial Sources.